Concure Oncology raises $3 million to advance Breast Microseed radioactive-seed treatment for early-stage breast cancer
Concure Oncology raised $3 million in a new SEC filing to fund its Breast Microseed brachytherapy treatment, which uses tiny radioactive titanium seeds to kill remaining cancer cells after tumor removal and prevent recurrence in early-stage breast cancer patients.